| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $473K | -34.6% |
| Cost of Revenue | $26K | -91.0% |
| R&D Expense | $31.9M | +12.3% |
| SG&A Expense | $16.9M | -23.0% |
| Operating Income | -$48.4M | +3.1% |
| Pre-tax Income | -$29.9M | -194.2% |
| Income Tax | $0 | +100.0% |
| Net Income | -$29.9M | -207.2% |
| EPS (Basic) | -$0.46 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.3M | -63.6% |
| Short-term Investments | $5.0M | — |
| Accounts Receivable | $189K | +285.7% |
| Inventory | $43K | +4.9% |
| Current Assets | $29.2M | -46.5% |
| Total Assets | $44.5M | -29.4% |
| Current Liabilities | $13.9M | +130.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.0M | -12.7% |
| Capital Expenditures | $5.2M | +288.8% |
| Investing Cash Flow | -$10.2M | -663.1% |
| Financing Cash Flow | $17.2M | -36.4% |
| Free Cash Flow | -$44.2M | -22.9% |
| -187.5% |
| Total Liabilities |
| $41.3M |
| -18.2% |
| Stockholders' Equity | $3.2M | -74.3% |